09:44 AM EST - BioVaxys Technology Corp. : Announced today its sponsorship of this year's World Ovarian Cancer Day, a major initiative of the World Ovarian Cancer Coalition, an international non-profit organization registered in Canada. James Passin , Chief Executive Officer of BioVaxys, stated, "It is an honor to partner with the World Ovarian Cancer Coalition and to support its important global patient advocacy work. As we approach World Ovarian Cancer Day, BioVaxys commits to advancing BVX-0918A through clinical and commercial development." BioVaxys Technology Corp.
shares C.BIOV are trading unchanged at $0.36.
